A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt.

Despite much progress in surveillance and biological research, no explanation exists to date for the epidemic pattern of meningitis in the African meningitis belt, which is required to mathematically model the impact of vaccine strategies or to predict epidemics. This paper presents a hypothetical explanatory model for epidemic meningococcal meningitis. Four incidence patterns are defined as model states, including endemic incidence during the rainy season, ubiquitous hyperendemicity during the dry season, occasional localized epidemics, and-at the regional level-regular epidemic waves spanning over communities or years. While the transition from endemic to hyperendemic situation in a community is caused by an increase in risk of meningitis given colonization by a virulent meningococcus (due to damage of the pharyngeal mucosa by dry climate), the transition from hyperendemic to epidemic situation involves increased pharyngeal colonization and transmission (possibly caused by viral respiratory infection epidemics). The described mechanisms are sufficient to explain the 10- to 100-fold incidence increase that both transitions usually imply. Epidemic waves occur if new meningococcal strains which escape pre-existing immunity, enter the population. Future research should include the impact of viral co-infection on bacterial colonization and invasion.

[1]  J. M. Griffiss.  Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model. , 1982, Reviews of infectious diseases.

[2]  A. Deghmane,et al.  The duality of virulence and transmissibility in Neisseria meningitidis. , 2002, Trends in microbiology.

[3]  J. Kimpen,et al.  Respiratory viral infection predisposing for bacterial disease: a concise review. , 1999, FEMS immunology and medical microbiology.

[4]  S. Janicot,et al.  Relationships between climate and year-to-year variability in meningitis outbreaks: A case study in Burkina Faso and Niger , 2008, International journal of health geographics.

[5]  A. Sié,et al.  ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study , 2008, Tropical medicine & international health.

[6]  F. Emele,et al.  Nasopharyngeal carriage of meningococcus and meningococcal meningitis in Sokoto, Nigeria , 1999, Acta paediatrica.

[7]  B. Gessner,et al.  Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines , 2006, Expert review of vaccines.

[8]  M. Thomson,et al.  Potential of environmental models to predict meningitis epidemics in Africa , 2006, Tropical medicine & international health : TM & IH.

[9]  J. Feeley,et al.  A simultaneous outbreak of meningococcal and influenza infections. , 1972, The New England journal of medicine.

[10]  R. Teyssou,et al.  Meningitis epidemics in Africa: a brief overview. , 2007, Vaccine.

[11]  B. Greenwood,et al.  An epidemic of meningococcal infection at Zaria, Northern Nigeria. 2. The changing clinical pattern. , 1979, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[12]  A. Fontanet,et al.  Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso , 2008, Tropical medicine & international health : TM & IH.

[13]  M. Taha,et al.  Viroses respiratoires et surinfections bactériennes invasives: Le cas de la grippe et des méningococcies , 2003 .

[14]  Jean-François Guégan,et al.  Climate Drives the Meningitis Epidemics Onset in West Africa , 2005, PLoS medicine.

[15]  B. Greenwood,et al.  Epidemic meningitis, meningococcaemia, and Neisseria meningitidis , 2007, The Lancet.

[16]  B. Gessner,et al.  Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003. , 2006, The Journal of infectious diseases.

[17]  B. Gessner,et al.  Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  D. Levy-bruhl,et al.  Epidemiology of invasive meningococcal disease in France in 2003. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[19]  P. Moore,et al.  Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  B. Gessner,et al.  The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  F. Ramisse,et al.  A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice. , 2003, FEMS microbiology letters.

[22]  O. Sow,et al.  [A study of Neisseria meningitidis isolated in the Republic of Mali in 1970]. , 1974, Bulletin of the World Health Organization.

[23]  R. Webby,et al.  Respiratory Viruses Augment the Adhesion of Bacterial Pathogens to Respiratory Epithelium in a Viral Species- and Cell Type-Dependent Manner , 2006, Journal of Virology.

[24]  B. Greenwood,et al.  Manson Lecture. Meningococcal meningitis in Africa. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  S. Chanteau,et al.  Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  E. Bertherat,et al.  [First major epidemic caused by Neisseria meningitidis serogroup W135 in Africa?]. , 2002, Medecine tropicale : revue du Corps de sante colonial.

[27]  S. Chanteau,et al.  Prospective survey on carriage of Neisseria meningitidis and protective immunity to meningococci in schoolchildren in Niamey (Niger): focus on serogroup W135. , 2006, Microbes and infection.

[28]  B. Greenwood,et al.  Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy? , 2000, The Lancet.

[29]  B. Greenwood,et al.  Comparative study of group A and group C meningococcal infection. , 1977, Archives of disease in childhood.

[30]  T. Popović,et al.  Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. , 2002, The Journal of infectious diseases.

[31]  B. Greenwood,et al.  Meningococcal carriage in the African meningitis belt. , 2007, The Lancet. Infectious diseases.

[32]  D. Musher,et al.  Bacterial adherence to pharyngeal cells during viral infection. , 1980, The Journal of infectious diseases.

[33]  L. Lapeyssonnie.  [CEREBROSPINAL MENINGITIS IN AFRICA]. , 1963, Bulletin of the World Health Organization.

[34]  P. Hunter,et al.  Management of an outbreak of meningococcal meningitis in a Sudanese refugee camp in Northern Uganda , 2000, Epidemiology and Infection.

[35]  P. Moore,et al.  Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. , 1990, JAMA.

[36]  B. Greenwood,et al.  The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. , 1982, The Journal of infectious diseases.

[37]  T. Popović,et al.  Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002. , 2006, The Journal of infectious diseases.

[38]  B. Gessner,et al.  Molecular Characteristics and Epidemiology of Meningococcal Carriage, Burkina Faso, 2003 , 2007, Emerging infectious diseases.

[39]  S. Chanteau,et al.  Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135 , 2005, Tropical medicine & international health : TM & IH.

[40]  B. Gessner,et al.  Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  W John Edmunds,et al.  Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. , 2005, American journal of epidemiology.

[42]  D. Caugant,et al.  Molecular Epidemiology of Neisseria meningitidis Isolated in the African Meningitis Belt between 1988 and 2003 Shows Dominance of Sequence Type 5 (ST-5) and ST-11 Complexes , 2005, Journal of Clinical Microbiology.

[43]  Andrew P. Morse,et al.  Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[44]  G. Pluschke,et al.  An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. , 2005, The Journal of infectious diseases.

[45]  A. Pollard,et al.  Development of natural immunity to Neisseria meningitidis. , 2001, Vaccine.

[46]  M. Achtman,et al.  Clonal Waves of Neisseria Colonisation and Disease in the African Meningitis Belt: Eight- Year Longitudinal Study in Northern Ghana , 2007, PLoS medicine.

[47]  R. Hayes,et al.  Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia, West Africa. , 1987, The Journal of infection.

[48]  Mark A. Miller,et al.  Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa. , 1999, The Pediatric infectious disease journal.

[49]  Stephen J. Connor,et al.  Environmental Risk and Meningitis Epidemics in Africa , 2003, Emerging infectious diseases.

[50]  D. Lehmann,et al.  Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract , 2006, Vaccine.